Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antisense technology for cancer therapy: does it make sense?

× No keyword cloud information.

55 in total

1. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors: R V Giles; D M Tidd
Journal: Nucleic Acids Res Date: 1992-02-25 Impact factor: 16.971

2. Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better.

Authors: D Herschlag
Journal: Proc Natl Acad Sci U S A Date: 1991-08-15 Impact factor: 11.205

3. Antisense inhibition of ras p21 expression that is sensitive to a point mutation.

Authors: E H Chang; P S Miller; C Cushman; K Devadas; K F Pirollo; P O Ts'o; Z P Yu
Journal: Biochemistry Date: 1991-08-27 Impact factor: 3.162

4. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct.

Authors: L Perlaky; B C Valdez; R K Busch; R G Larson; S M Jhiang; W W Zhang; M Brattain; H Busch
Journal: Cancer Res Date: 1992-01-15 Impact factor: 12.701

5. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.

Authors: K J Scanlon; L Jiao; T Funato; W Wang; T Tone; J J Rossi; M Kashani-Sabet
Journal: Proc Natl Acad Sci U S A Date: 1991-12-01 Impact factor: 11.205

6. In situ detection of a heat-shock regulatory element binding protein using a soluble synthetic enhancer sequence.

Authors: A Harel-Bellan; A T Brini; D K Ferris; P Robin; W L Farrar
Journal: Nucleic Acids Res Date: 1989-06-12 Impact factor: 16.971

7. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

Authors: W Y Gao; F S Han; C Storm; W Egan; Y C Cheng
Journal: Mol Pharmacol Date: 1992-02 Impact factor: 4.436

8. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line.

Authors: M C Moroni; M C Willingham; L Beguinot
Journal: J Biol Chem Date: 1992-02-05 Impact factor: 5.157

9. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

Authors: P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal: Science Date: 1991-12-06 Impact factor: 47.728

10. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides.

Authors: T Skorski; C Szczylik; M Z Ratajczak; L Malaguarnera; A M Gewirtz; B Calabretta
Journal: J Exp Med Date: 1992-03-01 Impact factor: 14.307

12 in total

1. Gene therapy for cancers.

Authors: L Lashford
Journal: Arch Dis Child Date: 1994-12 Impact factor: 3.791

2. A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.

Authors: D Morelli; B Pozzi; J A Maier; S Ménard; M I Colnaghi; A Balsari
Journal: Nucleic Acids Res Date: 1995-11-25 Impact factor: 16.971

Review 3. Molecular oncology in pancreatic cancer.

Authors: S Gansauge; F Gansauge; H G Beger
Journal: J Mol Med (Berl) Date: 1996-06 Impact factor: 4.599

4. Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies.

Authors: Y Liao; Z Y Tang; K D Liu; S L Ye; Z Huang
Journal: J Cancer Res Clin Oncol Date: 1997 Impact factor: 4.553

Review 5. Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?

Authors: G H Mickisch
Journal: World J Urol Date: 1995 Impact factor: 4.226

Review 6. Human cell lines as models for multidrug resistance in solid tumours.

Authors: M Clynes; M Heenan; K Hall
Journal: Cytotechnology Date: 1993 Impact factor: 2.058

7. Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study.

Authors: F Plenat; N Klein-Monhoven; B Marie; J M Vignaud; A Duprez
Journal: Am J Pathol Date: 1995-07 Impact factor: 4.307

8. Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells.

Authors: K Kato; Y Hitomi; K Imamura; H Esumi
Journal: Br J Cancer Date: 2002-10-07 Impact factor: 7.640

9. Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.

Authors: C M Barton; N R Lemoine
Journal: Br J Cancer Date: 1995-03 Impact factor: 7.640

10. erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

Authors: R Colomer; R Lupu; S S Bacus; E P Gelmann
Journal: Br J Cancer Date: 1994-11 Impact factor: 7.640